Annual Short Term Debt
$6.34 M
-$4.22 M-39.96%
September 30, 2024
Summary
- As of February 12, 2025, ARWR annual short term debt is $6.34 million, with the most recent change of -$4.22 million (-39.96%) on September 30, 2024.
- During the last 3 years, ARWR annual short term debt has risen by +$4.09 million (+181.87%).
- ARWR annual short term debt is now -39.96% below its all-time high of $10.56 million, reached on September 30, 2023.
Performance
ARWR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$6.34 M
+$289.00 K+4.77%
September 30, 2024
Summary
- As of February 12, 2025, ARWR quarterly short term debt is $6.34 million, with the most recent change of +$289.00 thousand (+4.77%) on September 30, 2024.
- Over the past year, ARWR quarterly short term debt has increased by +$1.06 million (+20.00%).
- ARWR quarterly short term debt is now -39.96% below its all-time high of $10.56 million, reached on September 30, 2023.
Performance
ARWR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ARWR Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.0% | +20.0% |
| 3 y3 years | +181.9% | +181.9% |
| 5 y5 years | +100.0% | +181.9% |
ARWR Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | +181.9% | -40.0% | +138.1% |
| 5 y | 5-year | -40.0% | -100.0% | -40.0% | +1275.1% |
| alltime | all time | -40.0% | -100.0% | -40.0% | -100.0% |
Arrowhead Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $6.34 M(-40.0%) | $6.34 M(+4.8%) |
| Jun 2024 | - | $6.05 M(+14.5%) |
| Mar 2024 | - | $5.29 M(+54.5%) |
| Dec 2023 | - | $3.42 M(-67.6%) |
| Sep 2023 | $10.56 M(+280.5%) | $10.56 M(+274.2%) |
| Jun 2023 | - | $2.82 M(+4.1%) |
| Mar 2023 | - | $2.71 M(+1.8%) |
| Dec 2022 | - | $2.66 M(-4.0%) |
| Sep 2022 | $2.78 M(+23.4%) | $2.78 M(-3.7%) |
| Jun 2022 | - | $2.88 M(-0.9%) |
| Mar 2022 | - | $2.91 M(+3.0%) |
| Dec 2021 | - | $2.83 M(+25.6%) |
| Sep 2021 | $2.25 M(+105.5%) | $2.25 M(+74.4%) |
| Jun 2021 | - | $1.29 M(+1.4%) |
| Mar 2021 | - | $1.27 M(+7.5%) |
| Dec 2020 | - | $1.18 M(+8.0%) |
| Sep 2020 | $1.09 M(>+9900.0%) | $1.09 M(+8.2%) |
| Jun 2020 | - | $1.01 M(+47.0%) |
| Mar 2020 | - | $688.50 K(+49.3%) |
| Dec 2019 | - | $461.20 K(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | $223.80 K(+7.3%) | $223.80 K(+1.8%) |
| Jun 2018 | - | $219.90 K(+1.8%) |
| Mar 2018 | - | $216.00 K(+1.8%) |
| Dec 2017 | - | $212.20 K(+1.8%) |
| Sep 2017 | $208.50 K(+7.3%) | $208.50 K(+1.8%) |
| Jun 2017 | - | $204.80 K(+1.8%) |
| Mar 2017 | - | $201.20 K(+1.8%) |
| Dec 2016 | - | $197.70 K(+1.7%) |
| Sep 2016 | $194.30 K(-10.7%) | $194.30 K(-46.2%) |
| Jun 2016 | - | $361.10 K(+64.7%) |
| Mar 2016 | - | $219.30 K(+0.4%) |
| Dec 2015 | - | $218.40 K(+0.4%) |
| Sep 2015 | $217.50 K(-17.6%) | $217.50 K(+0.4%) |
| Jun 2015 | - | $216.70 K(+0.4%) |
| Mar 2015 | - | $215.80 K(+0.8%) |
| Dec 2014 | - | $214.00 K(-18.9%) |
| Sep 2014 | $264.00 K | $264.00 K(+0.3%) |
| Jun 2014 | - | $263.10 K(-79.2%) |
| Mar 2014 | - | $1.26 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $1.27 M(+6.6%) |
| Sep 2013 | $1.19 M(+278.9%) | $1.19 M(+4.2%) |
| Jun 2013 | - | $1.15 M(+4.3%) |
| Mar 2013 | - | $1.10 M(-4.6%) |
| Dec 2012 | - | $1.15 M(+265.9%) |
| Sep 2012 | $314.80 K(>+9900.0%) | $314.80 K(+47.7%) |
| Jun 2012 | - | $213.20 K(+0.8%) |
| Mar 2012 | - | $211.60 K(+1.0%) |
| Dec 2011 | - | $209.60 K(>+9900.0%) |
| Sep 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | - | $500.00 K(0.0%) |
| Sep 2010 | $500.00 K(-31.2%) | $500.00 K(-13.0%) |
| Jun 2010 | - | $574.80 K(-27.8%) |
| Mar 2010 | - | $796.40 K(-21.4%) |
| Dec 2009 | - | $1.01 M(+39.5%) |
| Sep 2009 | $726.50 K(-10.4%) | $726.50 K(-15.6%) |
| Jun 2009 | - | $860.40 K(+2.0%) |
| Mar 2009 | - | $843.40 K(+2.0%) |
| Dec 2008 | - | $826.80 K(+2.0%) |
| Sep 2008 | $810.50 K(+33.7%) | $810.50 K(+34.6%) |
| Jun 2003 | - | $602.00 K(-0.2%) |
| Mar 2003 | - | $603.00 K(-0.5%) |
| Dec 2002 | - | $606.00 K(0.0%) |
| Sep 2002 | $606.00 K(+15.2%) | $606.00 K(0.0%) |
| Jun 2002 | - | $606.00 K(+19.8%) |
| Mar 2002 | - | $506.00 K(-3.8%) |
| Dec 2001 | - | $526.00 K(0.0%) |
| Sep 2001 | $526.00 K(+0.4%) | $526.00 K(0.0%) |
| Jun 2001 | - | $526.00 K(0.0%) |
| Mar 2001 | - | $526.00 K(+0.2%) |
| Dec 2000 | - | $525.00 K(+0.2%) |
| Sep 2000 | $524.00 K(+0.4%) | $524.00 K(+0.2%) |
| Jun 2000 | - | $523.00 K(-0.4%) |
| Mar 2000 | - | $525.00 K(0.0%) |
| Dec 1999 | - | $525.00 K |
| Sep 1999 | $522.00 K(-49.1%) | - |
| Sep 1998 | $1.02 M(+0.1%) | - |
| Sep 1997 | $1.02 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual short term debt year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly short term debt year-on-year change?
What is Arrowhead Pharmaceuticals annual short term debt?
The current annual short term debt of ARWR is $6.34 M
What is the all time high annual short term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual short term debt is $10.56 M
What is Arrowhead Pharmaceuticals annual short term debt year-on-year change?
Over the past year, ARWR annual short term debt has changed by -$4.22 M (-39.96%)
What is Arrowhead Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of ARWR is $6.34 M
What is the all time high quarterly short term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly short term debt is $10.56 M
What is Arrowhead Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, ARWR quarterly short term debt has changed by +$1.06 M (+20.00%)